Archeon
Archeon Medical is a French MedTech company developing AI-powered ventilation feedback devices (EOlife and EOlife X) that provide real-time monitoring of manual ventilation during CPR, serving EMS providers, firefighters, hospitals, and healthcare training institutions.
- Company typePrivate
- Founded2017
- HeadquartersBesançon, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Archeon does
Archeon Medical (legal entity ARCHEON SAS) is a privately held French MedTech company headquartered in Besançon, France, founded in 2017. The company specializes in AI-powered ventilation feedback devices designed for real-time monitoring of manual ventilation parameters during CPR and emergency care. Its core product, EOlife, is a medical-grade device that connects between a Bag Valve Mask (BVM) and the patient to measure volume insufflated, tidal volume, ventilation frequency, and air leaks. The proprietary FlowSense sensor technology, combined with in-house AI algorithms that infer tidal volume from inspiratory and expiratory flow curves, underpins the product. A complementary training device, EOlife X, is sold for use on mannequins and patient simulators and integrates via Bluetooth with the EOlife Connect mobile application (iOS and Android) for performance analysis against ERC and AHA international guidelines.
The business model is a hardware-plus-consumables structure. Revenue is generated from one-time device sales (EOlife for clinical use and EOlife X for training) and recurring sales of single-use FlowSense sensors, which must be replaced after each clinical use or every three months in the training device. Go-to-market is a hybrid of direct enterprise sales (targeting EMS, firefighters, and hospitals) for the clinically certified EOlife and a global authorized distributor channel for the certification-free EOlife X. The company is a venture-backed startup, having closed a €5.5M Series A in March 2022 led by Daphni, Karot Capital, and Majycc Innovation Santé with Bpifrance participation, and a follow-on Bpifrance instrument in July 2024. As of November 2025, the company is mid-execution on its first US clinical program, with concurrent trials in Chicago, Portland, and St. Louis aimed at validating its tripling-of-survival-rate outcome for US regulatory submission. Customer concentration spans three primary verticals: Emergency Medical Services, Healthcare Training Institutions, and Hospitals, with European public funder support (European Commission, iLab, French Tech, INPI) reinforcing its institutional positioning.
Archeon firmographics
Firmographics- Name
- Archeon
- Legal name
- ARCHEON
- Website
- https://archeon-medical.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Archeon Medical is a French MedTech company developing AI-powered ventilation feedback devices (EOlife and EOlife X) that provide real-time monitoring of manual ventilation during CPR, serving EMS providers, firefighters, hospitals, and healthcare training institutions.
- Ownership category
- akta.pro rank
Archeon industry classification
Industry- Product category
- Medical Ventilation Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where Archeon is headquartered
LocationHeadquarters
- HQ city
- Besançon
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Archeon business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Device Sales (EOlife): Sale of EOlife, an AI-powered ventilation feedback device for clinical/emergency use. This is the primary medical device sold to first responders, EMS services, and healthcare providers for use during cardiac emergencies.
- Training Device Sales (EOlife X): Sale of EOlife X, a training version of the ventilation feedback device designed for CPR training on mannequins. Used by training institutions and EMS training centers.
- Consumables (FlowSense Sensors): Single-use FlowSense sensors that must be replaced after each use (EOlife) or every 3 months (EOlife X). Revenue generated from ongoing consumable purchases by device customers.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Archeon product offering
Product offeringCore offering
Archeon Medical develops and sells AI-powered ventilation feedback devices (EOlife, EOlife X) that provide real-time monitoring of manual ventilation parameters—volume insufflated, tidal volume, ventilation frequency, and air leaks—during CPR and emergency medical care. The offering is complemented by the EOlife Connect mobile application for performance analysis and by proprietary single-use FlowSense sensors that form the recurring consumable revenue stream. Customers are emergency medical services, firefighters, hospitals, and CPR training institutions in France, the United States, and other international markets.
Product overview
Archeon Medical offers a portfolio of AI-powered ventilation feedback devices and training solutions. The core product is EOlife, a medical device for real-time ventilation monitoring during CPR and emergency care. EOlife X is a training-specific version for mannequin-based CPR education. Both devices use proprietary AI algorithms to estimate tidal volume and analyze ventilation quality. The ecosystem is supported by the EOlife Connect mobile app for data synchronization and analysis, and proprietary FlowSense/FlowSense X sensors for ventilation measurement.
Differentiator
Problem solved
Functional benefit
Brands
- EOlife: AI-powered ventilation feedback device for manual ventilation during CPR; a medical device intended for clinical use on adult patients.
- EOlife X
- EOlife Connect
Products and services
- EOlife AI-powered medical ventilation feedback device that provides real-time monitoring of ventilation parameters (tidal volume, ventilation frequency, leaks) during CPR and emergency care. Designed for use by first responders on adult patients to improve survival rates in cardiac emergencies.
- EOlife X Ventilation feedback device designed for CPR training on mannequins or patient simulators. Unlike EOlife, EOlife X is for training only and includes Bluetooth data download capability, blind recording mode, and pediatric training mode. Compatible with all market balloons, masks, tracheal tubes, and supraglottic devices.
- EOlife Connect Mobile application (iOS/Android) that allows importing, analyzing, and monitoring manual ventilation performance during training sessions with EOlife X. Provides feedback on ventilation quality and compliance with international recommendations, analyzing ventilation rate, insufflated volume, tidal volume, and leaks.
Quantifiable outcome
- Tripled survival rates with full neurological recovery in cardiac arrest care
- +3 more outcomes
Companies that use Archeon
Customer profileSegments3 records
Ideal customer profiles3 records
Archeon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability3 records
Feature3 records
Archeon partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Archeon competitors and assessment
Company assessmentDirect peers
- ZOLL Medical (Asahi Kasei): ZOLL is a leading resuscitation medical device company with CPR feedback technology (compression depth/rate via Real CPR Help) and is a natural competitor as Archeon extends feedback from compressions to ventilation. ZOLL serves the same EMS, fire, and hospital customer base globally.
- Laerdal Medical: Laerdal is a dominant player in CPR training (Resusci Anne, QCPR) and resuscitation devices, including BVMs. It competes directly with EOlife X in the CPR training market and overlaps with EOlife in ventilation quality improvement initiatives.
- 3B Scientific: 3B Scientific is a global provider of medical simulation and CPR training manikins (e.g., Resusci Anne family) used by healthcare training institutions — the same buyer segment that purchases EOlife X for ventilation technique training.
Broad incumbents
- Philips: Philips is a global leader in hospital ventilators, patient monitoring, and AEDs, serving EMS and hospital customers. Its integrated resuscitation/monitoring platforms represent a broad competitive threat to a niche ventilation feedback device like EOlife.
- Mindray: Mindray is a major manufacturer of patient monitoring and life-science medical devices sold globally, including to EMS-adjacent hospital departments. It competes broadly in the clinical vital-signs monitoring category that includes ventilation parameters.
- Dräger: Dräger manufactures ICU and transport ventilators, patient monitoring, and anesthesia equipment for hospitals and EMS. Its ventilator and monitoring portfolio positions it as a broad incumbent whose products overlap with Archeon's clinical ventilation quality use case.
- Intersurgical: Intersurgical designs and manufactures airway management and anesthesia products, including BVMs and supraglottic airways, which are compatible with EOlife. As an incumbent airway supplier to EMS, it is a comparable channel participant in the ventilation workflow.
- Stryker (Physio-Control / Lucas): Stryker's emergency medical division (formerly Physio-Control) sells LIFEPAK defibrillators, CPR assist devices (LUCAS), and resuscitation accessories to EMS and hospitals — the same buyer base as Archeon, and a likely platform competitor for integrated CPR quality feedback.
- Ambu: Ambu is a major manufacturer of single-use BVMs and airway management devices used in the same EMS and clinical workflows where EOlife operates. As a BVM incumbent, Ambu could bundle ventilation feedback into its established product portfolio.
Emerging players
- Nihon Kohden: Nihon Kohden is a specialist in patient monitoring and EEG/cardiac output measurement with growing EMS exposure. Its real-time physiological monitoring focus aligns with Archeon's real-time ventilation feedback value proposition for emergency and critical care settings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Archeon social profiles
Digital presenceArcheon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Archeon leadership team
Management profileNumber of profiles
Profiles2 records
Archeon funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Archeon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Archeon
What does Archeon do?
Archeon Medical develops and sells AI-powered ventilation feedback devices (EOlife, EOlife X) that provide real-time monitoring of manual ventilation parameters—volume insufflated, tidal volume, ventilation frequency, and air leaks—during CPR and emergency medical care. The offering is complemented by the EOlife Connect mobile application for performance analysis and by proprietary single-use FlowSense sensors that form the recurring consumable revenue stream. Customers are emergency medical services, firefighters, hospitals, and CPR training institutions in France, the United States, and other international markets.
Is Archeon a public or private company?
Archeon is a private company. It is classified as venture growth investor backed and is currently operating.
When was Archeon founded?
Archeon was founded in 2017. It employs 11 to 50 people.
Where is Archeon based?
Archeon is headquartered in Besançon, France, in the Europe region.
How does Archeon make money?
Three revenue lines are on record. Medical Device Sales (EOlife) is the primary driver. The others are training Device Sales (EOlife X) and consumables (FlowSense Sensors).
Who are Archeon's main competitors?
Direct peers on record are ZOLL Medical (Asahi Kasei), Laerdal Medical and 3B Scientific. Broad incumbents are Philips, Mindray, Dräger, Intersurgical, Stryker (Physio-Control / Lucas) and Ambu. Nihon Kohden is listed as an emerging player.
Does Archeon have an API?
No public API is recorded for Archeon.
What industry is Archeon in?
Archeon's product category is Medical Ventilation Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3841.